The global RNA Medicine market was valued at million in 2024 and is projected to reach US$ million by 2032, at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
We have surveyed the RNA Medicine companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks
This report aims to provide a comprehensive presentation of the global market for RNA Medicine, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding RNA Medicine. This report contains market size and forecasts of RNA Medicine in global, including the following market information:
Global RNA Medicine market revenue, 2020-2025, 2026-2032, ($ millions)
Global top five RNA Medicine companies in 2024 (%)
Total Market by Segment:
Global RNA Medicine market, by Type, 2020-2025, 2026-2032 ($ millions)
Global RNA Medicine market segment percentages, by Type, 2024 (%)
siRNA
ASO
miRNA
Nucleic Acid Aptamers
Global RNA Medicine market, by Application, 2020-2025, 2026-2032 ($ millions)
Global RNA Medicine market segment percentages, by Application, 2024 (%)
Cancer
Diabetes
Tuberculosis
Cardiovascular Diseases
Others
Global RNA Medicine market, by region and country, 2020-2025, 2026-2032 ($ millions)
Global RNA Medicine market segment percentages, by region and country, 2024 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies RNA Medicine revenues in global market, 2020-2025 (estimated), ($ millions)
Key companies RNA Medicine revenues share in global market, 2024 (%)
Further, the report presents profiles of competitors in the market, key players include:
Pfizer
Roche
Sanofi-Aventis
Abbott Laboratories
Arrowhead Pharmaceuticals
Benitec Biopharma
Calimmune Inc
Dicerna
Gradalis
Quark
RXi
Senesco
Silence Therapeutics
Silenseed
Tekmira
Alnylam Pharmaceuticals
Outline of Major Chapters:
Chapter 1: Introduces the definition of RNA Medicine, market overview.
Chapter 2: Global RNA Medicine market size in revenue.
Chapter 3: Detailed analysis of RNA Medicine company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of RNA Medicine in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 RNA Medicine Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 Global RNA Medicine Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global RNA Medicine Overall Market Size
2.1 Global RNA Medicine Market Size: 2024 VS 2032
2.2 Global RNA Medicine Market Size, Prospects & Forecasts: 2020-2032
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top RNA Medicine Players in Global Market
3.2 Top Global RNA Medicine Companies Ranked by Revenue
3.3 Global RNA Medicine Revenue by Companies
3.4 Top 3 and Top 5 RNA Medicine Companies in Global Market, by Revenue in 2024
3.5 Global Companies RNA Medicine Product Type
3.6 Tier 1, Tier 2, and Tier 3 RNA Medicine Players in Global Market
3.6.1 List of Global Tier 1 RNA Medicine Companies
3.6.2 List of Global Tier 2 and Tier 3 RNA Medicine Companies
4 Sights by Product
4.1 Overview
4.1.1 Segmentation by Type - Global RNA Medicine Market Size Markets, 2024 & 2032
4.1.2 siRNA
4.1.3 ASO
4.1.4 miRNA
4.1.5 Nucleic Acid Aptamers
4.2 Segmentation by Type - Global RNA Medicine Revenue & Forecasts
4.2.1 Segmentation by Type - Global RNA Medicine Revenue, 2020-2025
4.2.2 Segmentation by Type - Global RNA Medicine Revenue, 2026-2032
4.2.3 Segmentation by Type - Global RNA Medicine Revenue Market Share, 2020-2032
5 Sights by Application
5.1 Overview
5.1.1 Segmentation by Application - Global RNA Medicine Market Size, 2024 & 2032
5.1.2 Cancer
5.1.3 Diabetes
5.1.4 Tuberculosis
5.1.5 Cardiovascular Diseases
5.1.6 Others
5.2 Segmentation by Application - Global RNA Medicine Revenue & Forecasts
5.2.1 Segmentation by Application - Global RNA Medicine Revenue, 2020-2025
5.2.2 Segmentation by Application - Global RNA Medicine Revenue, 2026-2032
5.2.3 Segmentation by Application - Global RNA Medicine Revenue Market Share, 2020-2032
6 Sights by Region
6.1 By Region - Global RNA Medicine Market Size, 2024 & 2032
6.2 By Region - Global RNA Medicine Revenue & Forecasts
6.2.1 By Region - Global RNA Medicine Revenue, 2020-2025
6.2.2 By Region - Global RNA Medicine Revenue, 2026-2032
6.2.3 By Region - Global RNA Medicine Revenue Market Share, 2020-2032
6.3 North America
6.3.1 By Country - North America RNA Medicine Revenue, 2020-2032
6.3.2 United States RNA Medicine Market Size, 2020-2032
6.3.3 Canada RNA Medicine Market Size, 2020-2032
6.3.4 Mexico RNA Medicine Market Size, 2020-2032
6.4 Europe
6.4.1 By Country - Europe RNA Medicine Revenue, 2020-2032
6.4.2 Germany RNA Medicine Market Size, 2020-2032
6.4.3 France RNA Medicine Market Size, 2020-2032
6.4.4 U.K. RNA Medicine Market Size, 2020-2032
6.4.5 Italy RNA Medicine Market Size, 2020-2032
6.4.6 Russia RNA Medicine Market Size, 2020-2032
6.4.7 Nordic Countries RNA Medicine Market Size, 2020-2032
6.4.8 Benelux RNA Medicine Market Size, 2020-2032
6.5 Asia
6.5.1 By Region - Asia RNA Medicine Revenue, 2020-2032
6.5.2 China RNA Medicine Market Size, 2020-2032
6.5.3 Japan RNA Medicine Market Size, 2020-2032
6.5.4 South Korea RNA Medicine Market Size, 2020-2032
6.5.5 Southeast Asia RNA Medicine Market Size, 2020-2032
6.5.6 India RNA Medicine Market Size, 2020-2032
6.6 South America
6.6.1 By Country - South America RNA Medicine Revenue, 2020-2032
6.6.2 Brazil RNA Medicine Market Size, 2020-2032
6.6.3 Argentina RNA Medicine Market Size, 2020-2032
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa RNA Medicine Revenue, 2020-2032
6.7.2 Turkey RNA Medicine Market Size, 2020-2032
6.7.3 Israel RNA Medicine Market Size, 2020-2032
6.7.4 Saudi Arabia RNA Medicine Market Size, 2020-2032
6.7.5 UAE RNA Medicine Market Size, 2020-2032
7 Companies Profiles
7.1 Pfizer
7.1.1 Pfizer Corporate Summary
7.1.2 Pfizer Business Overview
7.1.3 Pfizer RNA Medicine Major Product Offerings
7.1.4 Pfizer RNA Medicine Revenue in Global Market (2020-2025)
7.1.5 Pfizer Key News & Latest Developments
7.2 Roche
7.2.1 Roche Corporate Summary
7.2.2 Roche Business Overview
7.2.3 Roche RNA Medicine Major Product Offerings
7.2.4 Roche RNA Medicine Revenue in Global Market (2020-2025)
7.2.5 Roche Key News & Latest Developments
7.3 Sanofi-Aventis
7.3.1 Sanofi-Aventis Corporate Summary
7.3.2 Sanofi-Aventis Business Overview
7.3.3 Sanofi-Aventis RNA Medicine Major Product Offerings
7.3.4 Sanofi-Aventis RNA Medicine Revenue in Global Market (2020-2025)
7.3.5 Sanofi-Aventis Key News & Latest Developments
7.4 Abbott Laboratories
7.4.1 Abbott Laboratories Corporate Summary
7.4.2 Abbott Laboratories Business Overview
7.4.3 Abbott Laboratories RNA Medicine Major Product Offerings
7.4.4 Abbott Laboratories RNA Medicine Revenue in Global Market (2020-2025)
7.4.5 Abbott Laboratories Key News & Latest Developments
7.5 Arrowhead Pharmaceuticals
7.5.1 Arrowhead Pharmaceuticals Corporate Summary
7.5.2 Arrowhead Pharmaceuticals Business Overview
7.5.3 Arrowhead Pharmaceuticals RNA Medicine Major Product Offerings
7.5.4 Arrowhead Pharmaceuticals RNA Medicine Revenue in Global Market (2020-2025)
7.5.5 Arrowhead Pharmaceuticals Key News & Latest Developments
7.6 Benitec Biopharma
7.6.1 Benitec Biopharma Corporate Summary
7.6.2 Benitec Biopharma Business Overview
7.6.3 Benitec Biopharma RNA Medicine Major Product Offerings
7.6.4 Benitec Biopharma RNA Medicine Revenue in Global Market (2020-2025)
7.6.5 Benitec Biopharma Key News & Latest Developments
7.7 Calimmune Inc
7.7.1 Calimmune Inc Corporate Summary
7.7.2 Calimmune Inc Business Overview
7.7.3 Calimmune Inc RNA Medicine Major Product Offerings
7.7.4 Calimmune Inc RNA Medicine Revenue in Global Market (2020-2025)
7.7.5 Calimmune Inc Key News & Latest Developments
7.8 Dicerna
7.8.1 Dicerna Corporate Summary
7.8.2 Dicerna Business Overview
7.8.3 Dicerna RNA Medicine Major Product Offerings
7.8.4 Dicerna RNA Medicine Revenue in Global Market (2020-2025)
7.8.5 Dicerna Key News & Latest Developments
7.9 Gradalis
7.9.1 Gradalis Corporate Summary
7.9.2 Gradalis Business Overview
7.9.3 Gradalis RNA Medicine Major Product Offerings
7.9.4 Gradalis RNA Medicine Revenue in Global Market (2020-2025)
7.9.5 Gradalis Key News & Latest Developments
7.10 Quark
7.10.1 Quark Corporate Summary
7.10.2 Quark Business Overview
7.10.3 Quark RNA Medicine Major Product Offerings
7.10.4 Quark RNA Medicine Revenue in Global Market (2020-2025)
7.10.5 Quark Key News & Latest Developments
7.11 RXi
7.11.1 RXi Corporate Summary
7.11.2 RXi Business Overview
7.11.3 RXi RNA Medicine Major Product Offerings
7.11.4 RXi RNA Medicine Revenue in Global Market (2020-2025)
7.11.5 RXi Key News & Latest Developments
7.12 Senesco
7.12.1 Senesco Corporate Summary
7.12.2 Senesco Business Overview
7.12.3 Senesco RNA Medicine Major Product Offerings
7.12.4 Senesco RNA Medicine Revenue in Global Market (2020-2025)
7.12.5 Senesco Key News & Latest Developments
7.13 Silence Therapeutics
7.13.1 Silence Therapeutics Corporate Summary
7.13.2 Silence Therapeutics Business Overview
7.13.3 Silence Therapeutics RNA Medicine Major Product Offerings
7.13.4 Silence Therapeutics RNA Medicine Revenue in Global Market (2020-2025)
7.13.5 Silence Therapeutics Key News & Latest Developments
7.14 Silenseed
7.14.1 Silenseed Corporate Summary
7.14.2 Silenseed Business Overview
7.14.3 Silenseed RNA Medicine Major Product Offerings
7.14.4 Silenseed RNA Medicine Revenue in Global Market (2020-2025)
7.14.5 Silenseed Key News & Latest Developments
7.15 Tekmira
7.15.1 Tekmira Corporate Summary
7.15.2 Tekmira Business Overview
7.15.3 Tekmira RNA Medicine Major Product Offerings
7.15.4 Tekmira RNA Medicine Revenue in Global Market (2020-2025)
7.15.5 Tekmira Key News & Latest Developments
7.16 Alnylam Pharmaceuticals
7.16.1 Alnylam Pharmaceuticals Corporate Summary
7.16.2 Alnylam Pharmaceuticals Business Overview
7.16.3 Alnylam Pharmaceuticals RNA Medicine Major Product Offerings
7.16.4 Alnylam Pharmaceuticals RNA Medicine Revenue in Global Market (2020-2025)
7.16.5 Alnylam Pharmaceuticals Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. RNA Medicine Market Opportunities & Trends in Global Market
Table 2. RNA Medicine Market Drivers in Global Market
Table 3. RNA Medicine Market Restraints in Global Market
Table 4. Key Players of RNA Medicine in Global Market
Table 5. Top RNA Medicine Players in Global Market, Ranking by Revenue (2024)
Table 6. Global RNA Medicine Revenue by Companies, (US$, Mn), 2020-2025
Table 7. Global RNA Medicine Revenue Share by Companies, 2020-2025
Table 8. Global Companies RNA Medicine Product Type
Table 9. List of Global Tier 1 RNA Medicine Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 10. List of Global Tier 2 and Tier 3 RNA Medicine Companies, Revenue (US$, Mn) in 2024 and Market Share
Table 11. Segmentation by Type � Global RNA Medicine Revenue, (US$, Mn), 2024 & 2032
Table 12. Segmentation by Type - Global RNA Medicine Revenue (US$, Mn), 2020-2025
Table 13. Segmentation by Type - Global RNA Medicine Revenue (US$, Mn), 2026-2032
Table 14. Segmentation by Application� Global RNA Medicine Revenue, (US$, Mn), 2024 & 2032
Table 15. Segmentation by Application - Global RNA Medicine Revenue, (US$, Mn), 2020-2025
Table 16. Segmentation by Application - Global RNA Medicine Revenue, (US$, Mn), 2026-2032
Table 17. By Region� Global RNA Medicine Revenue, (US$, Mn), 2024 & 2032
Table 18. By Region - Global RNA Medicine Revenue, (US$, Mn), 2020-2025
Table 19. By Region - Global RNA Medicine Revenue, (US$, Mn), 2026-2032
Table 20. By Country - North America RNA Medicine Revenue, (US$, Mn), 2020-2025
Table 21. By Country - North America RNA Medicine Revenue, (US$, Mn), 2026-2032
Table 22. By Country - Europe RNA Medicine Revenue, (US$, Mn), 2020-2025
Table 23. By Country - Europe RNA Medicine Revenue, (US$, Mn), 2026-2032
Table 24. By Region - Asia RNA Medicine Revenue, (US$, Mn), 2020-2025
Table 25. By Region - Asia RNA Medicine Revenue, (US$, Mn), 2026-2032
Table 26. By Country - South America RNA Medicine Revenue, (US$, Mn), 2020-2025
Table 27. By Country - South America RNA Medicine Revenue, (US$, Mn), 2026-2032
Table 28. By Country - Middle East & Africa RNA Medicine Revenue, (US$, Mn), 2020-2025
Table 29. By Country - Middle East & Africa RNA Medicine Revenue, (US$, Mn), 2026-2032
Table 30. Pfizer Corporate Summary
Table 31. Pfizer RNA Medicine Product Offerings
Table 32. Pfizer RNA Medicine Revenue (US$, Mn) & (2020-2025)
Table 33. Pfizer Key News & Latest Developments
Table 34. Roche Corporate Summary
Table 35. Roche RNA Medicine Product Offerings
Table 36. Roche RNA Medicine Revenue (US$, Mn) & (2020-2025)
Table 37. Roche Key News & Latest Developments
Table 38. Sanofi-Aventis Corporate Summary
Table 39. Sanofi-Aventis RNA Medicine Product Offerings
Table 40. Sanofi-Aventis RNA Medicine Revenue (US$, Mn) & (2020-2025)
Table 41. Sanofi-Aventis Key News & Latest Developments
Table 42. Abbott Laboratories Corporate Summary
Table 43. Abbott Laboratories RNA Medicine Product Offerings
Table 44. Abbott Laboratories RNA Medicine Revenue (US$, Mn) & (2020-2025)
Table 45. Abbott Laboratories Key News & Latest Developments
Table 46. Arrowhead Pharmaceuticals Corporate Summary
Table 47. Arrowhead Pharmaceuticals RNA Medicine Product Offerings
Table 48. Arrowhead Pharmaceuticals RNA Medicine Revenue (US$, Mn) & (2020-2025)
Table 49. Arrowhead Pharmaceuticals Key News & Latest Developments
Table 50. Benitec Biopharma Corporate Summary
Table 51. Benitec Biopharma RNA Medicine Product Offerings
Table 52. Benitec Biopharma RNA Medicine Revenue (US$, Mn) & (2020-2025)
Table 53. Benitec Biopharma Key News & Latest Developments
Table 54. Calimmune Inc Corporate Summary
Table 55. Calimmune Inc RNA Medicine Product Offerings
Table 56. Calimmune Inc RNA Medicine Revenue (US$, Mn) & (2020-2025)
Table 57. Calimmune Inc Key News & Latest Developments
Table 58. Dicerna Corporate Summary
Table 59. Dicerna RNA Medicine Product Offerings
Table 60. Dicerna RNA Medicine Revenue (US$, Mn) & (2020-2025)
Table 61. Dicerna Key News & Latest Developments
Table 62. Gradalis Corporate Summary
Table 63. Gradalis RNA Medicine Product Offerings
Table 64. Gradalis RNA Medicine Revenue (US$, Mn) & (2020-2025)
Table 65. Gradalis Key News & Latest Developments
Table 66. Quark Corporate Summary
Table 67. Quark RNA Medicine Product Offerings
Table 68. Quark RNA Medicine Revenue (US$, Mn) & (2020-2025)
Table 69. Quark Key News & Latest Developments
Table 70. RXi Corporate Summary
Table 71. RXi RNA Medicine Product Offerings
Table 72. RXi RNA Medicine Revenue (US$, Mn) & (2020-2025)
Table 73. RXi Key News & Latest Developments
Table 74. Senesco Corporate Summary
Table 75. Senesco RNA Medicine Product Offerings
Table 76. Senesco RNA Medicine Revenue (US$, Mn) & (2020-2025)
Table 77. Senesco Key News & Latest Developments
Table 78. Silence Therapeutics Corporate Summary
Table 79. Silence Therapeutics RNA Medicine Product Offerings
Table 80. Silence Therapeutics RNA Medicine Revenue (US$, Mn) & (2020-2025)
Table 81. Silence Therapeutics Key News & Latest Developments
Table 82. Silenseed Corporate Summary
Table 83. Silenseed RNA Medicine Product Offerings
Table 84. Silenseed RNA Medicine Revenue (US$, Mn) & (2020-2025)
Table 85. Silenseed Key News & Latest Developments
Table 86. Tekmira Corporate Summary
Table 87. Tekmira RNA Medicine Product Offerings
Table 88. Tekmira RNA Medicine Revenue (US$, Mn) & (2020-2025)
Table 89. Tekmira Key News & Latest Developments
Table 90. Alnylam Pharmaceuticals Corporate Summary
Table 91. Alnylam Pharmaceuticals RNA Medicine Product Offerings
Table 92. Alnylam Pharmaceuticals RNA Medicine Revenue (US$, Mn) & (2020-2025)
Table 93. Alnylam Pharmaceuticals Key News & Latest Developments
List of Figures
Figure 1. RNA Medicine Product Picture
Figure 2. RNA Medicine Segment by Type in 2024
Figure 3. RNA Medicine Segment by Application in 2024
Figure 4. Global RNA Medicine Market Overview: 2024
Figure 5. Key Caveats
Figure 6. Global RNA Medicine Market Size: 2024 VS 2032 (US$, Mn)
Figure 7. Global RNA Medicine Revenue: 2020-2032 (US$, Mn)
Figure 8. The Top 3 and 5 Players Market Share by RNA Medicine Revenue in 2024
Figure 9. Segmentation by Type � Global RNA Medicine Revenue, (US$, Mn), 2024 & 2032
Figure 10. Segmentation by Type - Global RNA Medicine Revenue Market Share, 2020-2032
Figure 11. Segmentation by Application � Global RNA Medicine Revenue, (US$, Mn), 2024 & 2032
Figure 12. Segmentation by Application - Global RNA Medicine Revenue Market Share, 2020-2032
Figure 13. By Region - Global RNA Medicine Revenue Market Share, 2020-2032
Figure 14. By Country - North America RNA Medicine Revenue Market Share, 2020-2032
Figure 15. United States RNA Medicine Revenue, (US$, Mn), 2020-2032
Figure 16. Canada RNA Medicine Revenue, (US$, Mn), 2020-2032
Figure 17. Mexico RNA Medicine Revenue, (US$, Mn), 2020-2032
Figure 18. By Country - Europe RNA Medicine Revenue Market Share, 2020-2032
Figure 19. Germany RNA Medicine Revenue, (US$, Mn), 2020-2032
Figure 20. France RNA Medicine Revenue, (US$, Mn), 2020-2032
Figure 21. U.K. RNA Medicine Revenue, (US$, Mn), 2020-2032
Figure 22. Italy RNA Medicine Revenue, (US$, Mn), 2020-2032
Figure 23. Russia RNA Medicine Revenue, (US$, Mn), 2020-2032
Figure 24. Nordic Countries RNA Medicine Revenue, (US$, Mn), 2020-2032
Figure 25. Benelux RNA Medicine Revenue, (US$, Mn), 2020-2032
Figure 26. By Region - Asia RNA Medicine Revenue Market Share, 2020-2032
Figure 27. China RNA Medicine Revenue, (US$, Mn), 2020-2032
Figure 28. Japan RNA Medicine Revenue, (US$, Mn), 2020-2032
Figure 29. South Korea RNA Medicine Revenue, (US$, Mn), 2020-2032
Figure 30. Southeast Asia RNA Medicine Revenue, (US$, Mn), 2020-2032
Figure 31. India RNA Medicine Revenue, (US$, Mn), 2020-2032
Figure 32. By Country - South America RNA Medicine Revenue Market Share, 2020-2032
Figure 33. Brazil RNA Medicine Revenue, (US$, Mn), 2020-2032
Figure 34. Argentina RNA Medicine Revenue, (US$, Mn), 2020-2032
Figure 35. By Country - Middle East & Africa RNA Medicine Revenue Market Share, 2020-2032
Figure 36. Turkey RNA Medicine Revenue, (US$, Mn), 2020-2032
Figure 37. Israel RNA Medicine Revenue, (US$, Mn), 2020-2032
Figure 38. Saudi Arabia RNA Medicine Revenue, (US$, Mn), 2020-2032
Figure 39. UAE RNA Medicine Revenue, (US$, Mn), 2020-2032
Figure 40. Pfizer RNA Medicine Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 41. Roche RNA Medicine Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 42. Sanofi-Aventis RNA Medicine Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 43. Abbott Laboratories RNA Medicine Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 44. Arrowhead Pharmaceuticals RNA Medicine Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 45. Benitec Biopharma RNA Medicine Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 46. Calimmune Inc RNA Medicine Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 47. Dicerna RNA Medicine Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 48. Gradalis RNA Medicine Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 49. Quark RNA Medicine Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 50. RXi RNA Medicine Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 51. Senesco RNA Medicine Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 52. Silence Therapeutics RNA Medicine Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 53. Silenseed RNA Medicine Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 54. Tekmira RNA Medicine Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
Figure 55. Alnylam Pharmaceuticals RNA Medicine Revenue Year Over Year Growth (US$, Mn) & (2020-2025)
